The Cooper Companies, Inc.
Every calculator, already run for COO
Open the full toolkit →You have the numbers on COO. Get the argument.
A written report on which of these readings actually decide the outcome for The Cooper Companies, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
16 analysts covering COOAnalyst Price Target Disagreement for The Cooper Companies, Inc.
Wall Street's bull case implies +36% from the current price; the bear case implies +5%. A 31% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for COO
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, an…
COO — frequently asked
Is COO a buy right now?
Wall Street's consensus rating on The Cooper Companies, Inc. is Buy across 16 analysts, with a mean price target of $66.21 (+20% vs. the current $55.29). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is COO overvalued?
COO trades at 19.0x trailing earnings, against a DCF fair value of $77 per share. The current price implies 2% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
What is the analyst price target disagreement for The Cooper Companies, Inc.?
Analysts covering The Cooper Companies, Inc. (COO) range from a bear-case target of $58.00 to a bull-case high of $75.00, with a mean consensus target of $66.21 across 14 analysts. The spread of $17.00 (31% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare The Cooper Companies, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For The Cooper Companies, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full COO research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on The Cooper Companies, Inc., in minutes. 3 free reports included with every account — no credit card required.